Location History:
- La Jolla, CA (US) (2018 - 2020)
- San Diego, CA (US) (2022)
Company Filing History:
2 out of 88 
1 out of 99 Years Active: 2018-2022
Title: Dhanya Raveendra-Panickar: Innovator in Metabotropic Glutamate Receptor Modulation
Introduction
Dhanya Raveendra-Panickar is a prominent inventor based in La Jolla, CA (US). She has made significant contributions to the field of pharmacology, particularly in the development of metabotropic glutamate receptor negative allosteric modulators (NAMs). With a total of 3 patents to her name, her work has the potential to impact therapeutic strategies for various neurological conditions.
Latest Patents
Her latest patents focus on small molecule active metabotropic glutamate subtype-2 and -3 receptor negative allosteric modulators (NAMs). These patents provide compositions comprising the compounds and methods of using these compounds and compositions. The innovative nature of her work lies in the potential applications of these NAMs in treating disorders related to glutamate signaling.
Career Highlights
Throughout her career, Dhanya has worked with esteemed institutions such as the Sanford Burnham Prebys Medical Discovery Institute and the Sanford Burnham Medical Research Institute. Her research has contributed to advancing our understanding of metabotropic glutamate receptors and their role in neurological health.
Collaborations
Dhanya has collaborated with notable colleagues, including Nicholas David Peter Cosford and Douglas J. Sheffler. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapeutic solutions.
Conclusion
Dhanya Raveendra-Panickar's work in the field of metabotropic glutamate receptor modulation exemplifies the impact of innovative research on medical science. Her contributions continue to pave the way for advancements in treatment options for neurological disorders.